Shionogi and MPP sign licence agreement for COVID-19 oral antiviral treatment
Ensitrelvir is being evaluated for the treatment of COVID-19 to be administered as an oral tablet formulation taken once daily for five days.
Ensitrelvir is being evaluated for the treatment of COVID-19 to be administered as an oral tablet formulation taken once daily for five days.
Mandaviya felicitated voluntary blood donors and states/UTs that have done exemplary work
This new initiative will cater to the increasing number of patients in Karnataka in need of heart and lung Failure management and transplant
There is also a growing interest in whole generation sequencing (WGS)
The two-day meeting in the city was organized in collaboration with the University of Birmingham, Christian Medical College Ludhiana, and Birmingham Clinical Trials Unit
Funds raised will be used to develop technology and foster healthcare partnerships
Further, ICAR-IVRI have jointly developed a Lumpy Skin Disease vaccine and as soon as the technology is made available, Hester will acquire the same and manufacture and commercialize the Lumpy Skin disease Vaccine
The companies will leverage their respective proprietary technology platforms
RYALTRIS is a fixed-dose combination therapy that provides relief for the symptoms of SAR, both nasal and ocular, in one easy-to-use nasal spray
To set up 50 lifestyle modification centres across the UAE in the next 24 months
Subscribe To Our Newsletter & Stay Updated